Cargando…

Epidemiology and Prognostic Factors of Candidemia in Cancer Patients

AIM: The study of candidemia in cancer patients has been limited. This retrospective study aims to investigate the epidemiologic characteristics and prognostic factors of candidemia among cancer patients. MATERIALS AND METHODS: From 2009 to 2012, cancer patients with candidemia were identified at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hung-Jen, Liu, Wei-Lun, Lin, Hsin-Lan, Lai, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047064/
https://www.ncbi.nlm.nih.gov/pubmed/24901336
http://dx.doi.org/10.1371/journal.pone.0099103
_version_ 1782480359200391168
author Tang, Hung-Jen
Liu, Wei-Lun
Lin, Hsin-Lan
Lai, Chih-Cheng
author_facet Tang, Hung-Jen
Liu, Wei-Lun
Lin, Hsin-Lan
Lai, Chih-Cheng
author_sort Tang, Hung-Jen
collection PubMed
description AIM: The study of candidemia in cancer patients has been limited. This retrospective study aims to investigate the epidemiologic characteristics and prognostic factors of candidemia among cancer patients. MATERIALS AND METHODS: From 2009 to 2012, cancer patients with candidemia were identified at a hospital in Taiwan. The medical records of all patients with bloodstream infections due to Candida species were retrospectively reviewed. RESULTS: During the four-year period, a total of 242 episodes of candidemia were identified among cancer patients. Half of these patients were classified as elderly (≥65 years old), and more than 95% of the candidemia episodes were classified as healthcare-associated infections. Among the 242 cancer patients with candidemia, head and neck cancer was the most common, followed by gastrointestinal tract and lung cancer. Additionally, most of the patients had variable underlying conditions, such as the presence of CVC (99%) or prior exposure to broad-spectrum antibiotics (93%) and were receiving an immunosuppressant (86%). Overall, C. albicans (n = 132, 54.5%) was the most common pathogen, followed by C. tropicalis (n = 52, 21.5%), C. parapsilosis (n = 38, 15.7%), and C. glabrata (n = 29, 12.0%). Seventeen patients had polycandidal candidemia, and 77 patients had concomitant bacteremia. Approximately one-third of the patients required admission to the intensive care unit (ICU) or mechanical ventilation, and the overall in-hospital mortality was 50.8%. Multivariable analysis showed that the in-hospital mortality was significantly associated with only the non-use of antifungal agents and acute respiratory failure (P<.001). CONCLUSIONS: Candidemia can develop in patients with both solid cancer and hematological malignancy, especially for patients with underlying conditions. Overall, the associated morbidity and mortality due to Candidemia remain high. It was also determined that the non-use of antifungal agents and acute respiratory failure conditions were associated with in-hospital mortality.
format Online
Article
Text
id pubmed-4047064
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40470642014-06-09 Epidemiology and Prognostic Factors of Candidemia in Cancer Patients Tang, Hung-Jen Liu, Wei-Lun Lin, Hsin-Lan Lai, Chih-Cheng PLoS One Research Article AIM: The study of candidemia in cancer patients has been limited. This retrospective study aims to investigate the epidemiologic characteristics and prognostic factors of candidemia among cancer patients. MATERIALS AND METHODS: From 2009 to 2012, cancer patients with candidemia were identified at a hospital in Taiwan. The medical records of all patients with bloodstream infections due to Candida species were retrospectively reviewed. RESULTS: During the four-year period, a total of 242 episodes of candidemia were identified among cancer patients. Half of these patients were classified as elderly (≥65 years old), and more than 95% of the candidemia episodes were classified as healthcare-associated infections. Among the 242 cancer patients with candidemia, head and neck cancer was the most common, followed by gastrointestinal tract and lung cancer. Additionally, most of the patients had variable underlying conditions, such as the presence of CVC (99%) or prior exposure to broad-spectrum antibiotics (93%) and were receiving an immunosuppressant (86%). Overall, C. albicans (n = 132, 54.5%) was the most common pathogen, followed by C. tropicalis (n = 52, 21.5%), C. parapsilosis (n = 38, 15.7%), and C. glabrata (n = 29, 12.0%). Seventeen patients had polycandidal candidemia, and 77 patients had concomitant bacteremia. Approximately one-third of the patients required admission to the intensive care unit (ICU) or mechanical ventilation, and the overall in-hospital mortality was 50.8%. Multivariable analysis showed that the in-hospital mortality was significantly associated with only the non-use of antifungal agents and acute respiratory failure (P<.001). CONCLUSIONS: Candidemia can develop in patients with both solid cancer and hematological malignancy, especially for patients with underlying conditions. Overall, the associated morbidity and mortality due to Candidemia remain high. It was also determined that the non-use of antifungal agents and acute respiratory failure conditions were associated with in-hospital mortality. Public Library of Science 2014-06-05 /pmc/articles/PMC4047064/ /pubmed/24901336 http://dx.doi.org/10.1371/journal.pone.0099103 Text en © 2014 Tang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tang, Hung-Jen
Liu, Wei-Lun
Lin, Hsin-Lan
Lai, Chih-Cheng
Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
title Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
title_full Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
title_fullStr Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
title_full_unstemmed Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
title_short Epidemiology and Prognostic Factors of Candidemia in Cancer Patients
title_sort epidemiology and prognostic factors of candidemia in cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047064/
https://www.ncbi.nlm.nih.gov/pubmed/24901336
http://dx.doi.org/10.1371/journal.pone.0099103
work_keys_str_mv AT tanghungjen epidemiologyandprognosticfactorsofcandidemiaincancerpatients
AT liuweilun epidemiologyandprognosticfactorsofcandidemiaincancerpatients
AT linhsinlan epidemiologyandprognosticfactorsofcandidemiaincancerpatients
AT laichihcheng epidemiologyandprognosticfactorsofcandidemiaincancerpatients